Lyribea Capsule 50 mg (Pregabalin)

Adult dose

This medication is administered orally in two divided doses regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Initial dose of 150 mg/day; may increase to 300 mg/day after 3 to 7 days, and up to a maximum of 600 mg/day in intervals of 7 days if necessary. - Central neuropathic pain: Initial dose of 150 mg/day, may increase to 300 mg/day after 1 week.

Child dose

Administration is not recommended for children under 12 years of age and adolescents aged 12-17 due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behaviors, so you must consult a physician immediately if you experience symptoms of depression or mood changes while taking it. It should not be used if there is a hypersensitivity reaction to this medication. Diabetic patients should be cautious as weight gain may require adjustments to blood sugar control medications. In case of serious allergic reactions such as angioedema, the medication should be stopped immediately. Elderly individuals may be prone to side effects such as dizziness or drowsiness, so caution is advised until they become accustomed to the medication. Vision blurriness or changes in eyesight may occur, and if these symptoms occur, notify a healthcare provider. When discontinuing this medication, withdrawal symptoms such as insomnia, headache, and anxiety may occur; therefore, it should be stopped gradually in consultation with a healthcare professional. Patients with a history of substance abuse may be at a higher risk of misuse, and special caution is required when taking this medication. Patients with reduced kidney function may need dose adjustments. Patients with heart conditions should use this medication cautiously due to the risk of congestive heart failure. Co-administration with opioid analgesics can increase central nervous system depression, so caution is warranted. Individuals with respiratory or neurological diseases, as well as the elderly, are at higher risk of severe respiratory depression, so consultation with a physician is necessary prior to use. During early pregnancy, there is a risk of congenital malformations; thus, women who are pregnant or planning to become pregnant must consult a physician. Breastfeeding women should consult a healthcare provider regarding the potential transmission of this medication into breast milk and its effects on the infant. Caution is advised as dizziness and drowsiness can increase the risk of accidents during driving or operating machinery. Severe allergic skin reactions may occur, so if any abnormal symptoms such as rash or swelling develop, stop taking it immediately and notify a healthcare provider. In case of overdose, symptoms such as confusion, drowsiness, and convulsions may occur, and immediate medical attention is necessary if overdose is suspected.

Serious side effects

Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain on the mucous membranes of the mouth/eyes, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, markedly decreased urine output, generalized swelling with elevated blood pressure, neutropenia

Mild side effects

• Dizziness
• drowsiness
• confusion
• loss of coordination
• irritability
• depression
• euphoria
• reduced libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 15 to 30 degrees Celsius.

Appearance

Hard capsules with white upper and lower parts containing a white to pale yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle